Literature DB >> 15781950

Use of antibiotics and risk of breast cancer.

L A García Rodríguez1, A González-Pérez.   

Abstract

A recent nested case-control study found that increasing use of antibiotics was associated with a significantly elevated risk of breast cancer. The authors attempted to replicate this finding with a similar study design using the General Practice Research Database in the United Kingdom. Women aged 30-79 years who were registered in the database between January 1995 and December 2001 comprised the study cohort. A total of 3,708 women with incident cases of breast cancer and 20,000 frequency-matched controls were entered into a nested case-control analysis. Use of antibiotics was not associated with an increased risk of breast cancer. For categories of increasing cumulative days of use (1-50, 51-100, 101-500, and >or=501 days), the corresponding odds ratios were 1.0 (95% confidence interval (CI): 0.9, 1.1), 1.0 (95% CI: 0.8, 1.1), 0.9 (95% CI: 0.7, 1.0), and 1.2 (95% CI: 0.9, 1.6) (p = 0.31 for trend). On the basis of these results, antibiotic use does not appear to be a major determinant of breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781950     DOI: 10.1093/aje/kwi087

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  Periodontal Disease and Breast Cancer: Prospective Cohort Study of Postmenopausal Women.

Authors:  Jo L Freudenheim; Robert J Genco; Michael J LaMonte; Amy E Millen; Kathleen M Hovey; Xiaodan Mai; Ngozi Nwizu; Christopher A Andrews; Jean Wactawski-Wende
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-21       Impact factor: 4.254

2.  Lyme disease: Is it or is it not?

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

3.  Frequent antibiotic use and second breast cancer events.

Authors:  Heidi S Wirtz; Diana S M Buist; Julie R Gralow; William E Barlow; Shelly Gray; Jessica Chubak; Onchee Yu; Erin J A Bowles; Monica Fujii; Denise M Boudreau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-05       Impact factor: 4.254

Review 4.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

5.  Gut microbiome, body weight, and mammographic breast density in healthy postmenopausal women.

Authors:  Lusine Yaghjyan; Volker Mai; Xuefeng Wang; Maria Ukhanova; Maximiliano Tagliamonte; Yessica C Martinez; Shannan N Rich; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2021-03-27       Impact factor: 2.506

6.  Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions.

Authors:  Zhijun Ma; Manli Qu; Xiaowu Wang
Journal:  Pol J Microbiol       Date:  2022-05-31

7.  Can rye intake decrease risk of human breast cancer?

Authors:  Herman Adlercreutz
Journal:  Food Nutr Res       Date:  2010-11-10       Impact factor: 3.894

8.  Gentamicin arrests cancer cell growth: the intriguing involvement of nuclear sphingomyelin metabolism.

Authors:  Michela Codini; Samuela Cataldi; Francesco Saverio Ambesi-Impiombato; Andrea Lazzarini; Alessandro Floridi; Remo Lazzarini; Francesco Curcio; Tommaso Beccari; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

9.  Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Fausto Petrelli; Michele Ghidini; Antonio Ghidini; Gianluca Perego; Mary Cabiddu; Shelize Khakoo; Emanuela Oggionni; Chiara Abeni; Jens Claus Hahne; Gianluca Tomasello; Alberto Zaniboni
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

10.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.